38.107.191.114
MedPix® Medical Image DatabaseDisease Topic 5131
(Reviewed and Approved) :: Link to this Topic
Click Here for MedPix®-2
» » - - Print Topic - - « «
Contributor: Authors: James Grimson, MD, and Benjamin Drinkwine, MSIV, EVMS
Scroll to Bottom to Display Images (if available)
More Like This ? Acute Disseminated Encephalomyelitis (ADEM)
Factoid 5131 - Created: 2003-09-17 19:06:59-04 - Modified: 2003-10-22 18:36:26-04
ACR Codes: 1.2
Acute disseminated encephalomyelitis (ADEM) is a severe inflammatory, demyelinating disease of the central nervous system that typically occurs following vaccination or infection and may sometimes occur spontaneously.1,2 The pathogenesis of this disease is likely related to a transient autoimmune response to myelin. ADEM has been reported to follow a number of different immunizations and diseases, with the most commonly reported associated illness being a nonspecific upper respiratory infection.2

Disease symptoms begin approximately six weeks following antigenic challenge. The patient often experiences a prodrome of headache, low-grade fever, myalgias, and malaise several days prior to the onset of ADEM.2 Neurologic symptoms then develop rapidly, and may include meningeal signs, seizures, focal neurologic deficits, stupor, and coma.1 Hemiparesis, tetraparesis, cranial nerve palsies, and movement disorders may be apparent during the acute phase. CSF analysis may demonstrate abnormalities in the presence of ADEM, with moderately increase protein and leukocyte levels. Protein electrophoresis of the CSF often reveals oligoclonal bands of IgG, indicating intrathecal antibody production.3 The course of the disease is usually monophasic and affects children more often than adults. Peak severity of the disease occurs within several days, though it may occasionally evolve over several months. The mortality rate is 10-25%, and about 20-30% of survivors are left with permanent neurologic sequelae. Preferred treatment is with IV corticosteroids, which seem to halt disease progression and allow recovery sooner.2,3

In MR imaging, ADEM causes multiple sclerosis-like, but more asymmetrical, white matter lesions. Lesions have been reported to be evident by MR shortly after the onset of symptoms. Disappearance of the lesions is suggested to be associated with clinical recovery, although some reports indicate that the lesions may appear to worsen initially on follow-up imaging, while the patient recovers clinically.3 The lesions are usually multiple and tend to occur in the brainstem, cerebellum, basal ganglia, and deep white matter. T2-weighted MRI is significantly more sensitive than CT in identifying lesions of increased signal intensity in the white matter. The lesions are hypointense on T1-weighted images and may demonstrate solid or ring enhancement following administration of gadolinium.1 Lesions may later become hemorrhagic in a variant of ADEM known as acute hemorrhagic encephalomyelitis (AHEM).3
Reference(s):
1. Brant, William E. and Clyde A. Helms. Fundamentals of Diagnostic Radiology. 2nd ed. Pp. 157,176. 1999.
2. Goetz: Textbook of Clinical Neurology. 1st ed. Pp. 987-88. 1999.
3. Honkaniemi, Jari, et al. “Delayed MR Imaging Changes in Acute Disseminated Encephalomyelitis.” American Journal of Neuroradiology. 22:1117-1124, June/July 2001.
Display Images - || - Image Slide Sorter
Location:
Brain and Neuro
Sublocation:
none selected
Category:
Inflammatory, autoimmune
More Like This ? - Find Related Topics: Click on the Location, Sublocation, or Category Links Above
Send this Search to ... More Like This ?  - - CHORUS - - Google™
Written by: Authors: James Grimson, MD, and Benjamin Drinkwine, MSIV, EVMS
Prepared by:
James M Grimson
Affiliation: Naval Medical Center Portsmouth - || - Author Profile
Approved by: James C Mosure
Affiliation: Naval Medical Center Portsmouth - || - Editor Profile
-


Use this MedPix® Visitor Feedback Form for Comments and Suggestions


MedPix® is sponsored by the Department of Radiology and Radiological Sciences, USUHS, Bethesda, MD
We do not accept paid advertisements.

This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard
for trustworthy health information:
verify here.


Text and Images may be Copyrighted © 1999 - 2009 by the Original Content Contributors.
Copyrighted materials are reproduced here with their Permission.

MedPix® is a Registered Trademark of USUHS :: The MedPix® Database Engine is Patented - USPTO No. 7,080,098
Portions of MedPix® are Copyright © 1999 - 2009 by J.G. Smirniotopoulos, M.D. & H. Irvine, M.D.
The MedPix® Classification Schema Copyright © 1999 - 2009 by J.G.Smirniotopoulos,M.D.
MedPix® has displayed more than   266,932,384   pages since 3 September 2000.

Database Successfully Disconnected